EcoDrugPlus

Ribosomal Protein L26 Like 1

Ensembl ID : ENSSPAG00000008645
Gene Symbol: RPL26L1
3 Cross references
477 Possible Orthologues:

Ribosomal Protein L27

Ensembl ID : ENSSPAG00000010318
Gene Symbol: RPL27
3 Cross references
370 Possible Orthologues:

Ribosomal Protein L27a

Ensembl ID : ENSSPAG00000000134
Gene Symbol: RPL27A
4 Cross references
514 Possible Orthologues:

Ribosomal Protein L28

Ensembl ID : ENSSPAG00000015122
Gene Symbol: RPL28
3 Cross references
284 Possible Orthologues:

Ribosomal Protein L29

Ensembl ID : ENSSPAG00000020292
Gene Symbol: RPL29
1 Cross references
495 Possible Orthologues:

Ribosomal Protein L30

Ensembl ID : ENSSPAG00000019581
Gene Symbol: RPL30
3 Cross references
415 Possible Orthologues:

Ribosomal Protein L31

Ensembl ID : ENSSPAG00000009164
Gene Symbol: RPL31
3 Cross references
651 Possible Orthologues:

Ribosomal Protein L34

Ensembl ID : ENSSPAG00000019715
Gene Symbol: RPL34
3 Cross references
362 Possible Orthologues:

Ribosomal Protein L35

Ensembl ID : ENSSPAG00000020895
Gene Symbol: RPL35
3 Cross references
275 Possible Orthologues:

Ribosomal Protein L35a

Ensembl ID : ENSSPAG00000013060
Gene Symbol: RPL35A
3 Cross references
452 Possible Orthologues:

Ribosomal Protein L36

Ensembl ID : ENSSPAG00000011406
Gene Symbol: RPL36
3 Cross references
400 Possible Orthologues:

Ribosomal Protein L36a

Ensembl ID : ENSSPAG00000010411
Gene Symbol: RPL36A
4 Cross references
293 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).